Graduate student Karishma Dhuri presented her interesting work on “Targeting aberrant miRNAs for diverse therapeutic applications” as a part of UConn RNA Salon Graduate Student Seminar Series on February 19th 2021. Karishma’s work highlighted the strategy of simultaneously targeting two different oncomiRs for lymphoma therapy. The use of nucleic acid therapeutics to target a single miRNA for stroke therapy was also highlighted upon.

Dr. Bahal presented his work ”Therapeutic targeting of RNA’s for the development of precision medicine” as a part of ‘Therapeutic Innovation Scientific Talks’ webinar series on Friday, November 13th, 2020 hosted by AAPS Student chapter at St. John’s University. Dr. Bahal gave interesting insights about the role of non-coding RNAs for the treatment and diagnosis of cancer & other diseases.

Dr. Bahal presented his exciting work on ”Next-generation microRNA targeting at the interface of nucleic acid chemistry and nanotechnology”, highlighting the role of non-coding RNAs for the treatment and diagnosis of cancer & other diseases. The goal of the Harvard Medical School Initiative for RNA Medicine is to make and translate RNA discoveries into novel therapeutics and diagnostics by fostering a climate of outstanding basic, translational and clinical research with world-leading scientists and clinicians.

Check out our new articles, “Applications of PNA-laden nanoparticles for hematological disorders”; and “Advances in Nanoparticle-based Delivery of Next Generation Peptide Nucleic Acids”. Find them on our Publications page. Congratulations Team!